FDA Finalizes Guidance on Promotional Rules for Biosimilar Products
December 10, 2025
December 10, 2025
WASHINGTON, Dec. 10 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has announced the availability of a final guidance document to address questions about promotional labeling and advertising for prescription biological products.
This guidance entitled "Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers&quo . . .
This guidance entitled "Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers&quo . . .